Literature DB >> 2454950

SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.

B F Murphy1, L Kirszbaum, I D Walker, A J d'Apice.   

Abstract

We report herein the isolation and initial characterization of a novel protein, termed SP-40,40, which is present at moderate levels (35-105 micrograms/ml) in normal human serum. SP-40,40 is deposited in the renal glomeruli of patients with glomerulonephritis but is not found in normal glomeruli. The protein is a heterodimeric structure of relative molecular mass 80 kD, both chains of which are of a similar size (40 kD). The amino-terminal sequences of both chains are unrelated to one another and possess no significant homology to any known protein sequence. The tissue distribution of SP-40,40 closely resembles that of the terminal complement components and its physicochemical properties are similar to, but distinct from, those of the S protein of complement. We have identified SP-40,40 in the SC5b-9 complex of complement and have demonstrated incorporation of labeled SP-40,40 into this complex. These data suggest that SP-40,40 is an additional component of SC5b-9.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454950      PMCID: PMC442636          DOI: 10.1172/JCI113531

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Measurement of protein by spectrophotometry at 205 nm.

Authors:  R K Scopes
Journal:  Anal Biochem       Date:  1974-05       Impact factor: 3.365

2.  Human glomerular basement membrane. Preparation and composition.

Authors:  N G Westberg; A F Michael
Journal:  Biochemistry       Date:  1970-09-15       Impact factor: 3.162

3.  Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat.

Authors:  H Glossmann; D M Neville
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

4.  Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis.

Authors:  E W Rauterberg; H M Lieberknecht; A M Wingen; E Ritz
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

5.  Glomerular lesions after renal transplantation.

Authors:  T H Mathew; D C Mathews; J B Hobbs; P Kincaid-Smith
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

6.  Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  The C5b-6 complex: reaction with C7, C8, C9.

Authors:  E R Podack; G Biesecker; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

8.  The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

Authors:  E R Podack; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

10.  On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.

Authors:  C H Hammer; M L Shin; A S Abramovitz; M M Mayer
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

View more
  64 in total

1.  Overexpression of clusterin in human breast carcinoma.

Authors:  M Redondo; E Villar; J Torres-Muñoz; T Tellez; M Morell; C K Petito
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  SP-40,40 is a constituent of Alzheimer's amyloid.

Authors:  N H Choi-Miura; Y Ihara; K Fukuchi; M Takeda; Y Nakano; T Tobe; M Tomita
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 4.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

5.  What is clusterin?

Authors:  I B Fritz
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Unraveling the sperm proteome and post-genomic pathways associated with sperm nuclear DNA fragmentation.

Authors:  Paula Intasqui; Mariana Camargo; Paula T Del Giudice; Deborah M Spaine; Valdemir M Carvalho; Karina H M Cardozo; Agnaldo P Cedenho; Ricardo P Bertolla
Journal:  J Assist Reprod Genet       Date:  2013-07-27       Impact factor: 3.412

7.  Regulation of complement membrane attack complex formation in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

9.  Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.

Authors:  H Dauchel; P Joly; A Delpech; E Thomine; F Sauger; X Le Loet; P Lauret; F Tron; M Fontaine; J Ripoche
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.

Authors:  C M Verduin; M Jansze; C Hol; T E Mollnes; J Verhoef; H van Dijk
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.